<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.agingnexus.com/sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url><loc>https://www.agingnexus.com/works/investigation-of-the-relationship-between-sarcopenia-and-paclitaxel-in</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/evaluating-and-monitoring-physical-fatigue-while-performing-functional</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/effects-of-a-weight-based-training-program-on-bone-density-cognition</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/k2dtd75-altis-alimento-funzionale-a-base-di-lens-culinaris-tipico-d</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/semi-recumbent-vibration-therapy-in-older-adults</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/sarcopenia-a-new-issue-in-juvenile-idiopathic-arthritis</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/comparative-assessment-of-phase-angle-lean-body-mass-index-and-tissue</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/characterization-creativity-leadership-and-search-for-solutions-to-2</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/effect-of-individual-nutritional-therapy-in-patients-at-risk-for-malnu</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/the-effect-of-tai-chi-on-quality-of-life-and-depression-in-elderly-pat</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/construction-and-effect-evaluation-of-the-low-load-blood-flow-restrict</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/the-cardio-sarcopenia-study</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/could-a-preoperative-feeding-jejunostomy-decrease-sarcopenia-for-patie</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/concurrent-assessment-of-skeletal-muscle-mass-and-synthesisbreakdown</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/an-early-exploratory-clinical-trial-to-evaluate-cg-bm1-allogeneic-huma</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/effect-of-dietary-protein-intake-distribution-on-protein-metabolism-an</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/to-assess-prevalence-of-sarcopenia-using-hand-grip-strength-hgs-as-a</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-whey-protein-based-nutritional-supplement-enriched-in-vitamin-d-leu</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/benefits-of-a-renal-rehabilitation-program-adapted-to-uremic-patients</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/assessment-of-sarcopenia-physical-performance-and-cognitive-function</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/the-impact-of-ingesting-a-whole-food-animal-based-versus-plant-based-p</loc><lastmod>2026-11-04T11:20:37+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/prevalence-of-preoperative-sarcopenia-and-its-impact-on-surgical-outco</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/effects-of-creatine-supplementation-on-muscle-health-in-madrids-older</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/comparison-of-the-effects-of-resistance-and-aerobic-exercises-added-to</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/multivariate-analysis-and-risk-factors-were-used-to-predict-the-short</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-double-blind-placebo-controlled-research-study-evaluati</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/fludarabine-versus-chlorambucil-in-first-line-therapy-of-elderly-patie</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-single-center-prospective-single-arm-clinical-study-evaluating-the</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/livelung-impact-of-cga-on-qol-overall-survival-and-the-need-for-adm</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/biopsy-versus-resection-in-elderly-glioblastoma-patients-a-prospectiv</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-multicenter-open-randomized-controlled-phase-iib-trial-evaluating</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-open-label-phase-3-study-of-acalabrutinib-in-combinatio</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-double-blinded-placebo-controlled-clinical-trial-to-eva</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/special-care-patterns-for-elderly-hnscc-patients-undergoing-radiothera</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-multicenter-open-label-study-of-oral-melphalan-prednisone-and-cc</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-open-label-study-of-the-effect-of-first-line-treatment-w</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/feasibility-of-a-perioperative-physical-activity-intervention-for-olde</loc><lastmod>2026-11-04T11:20:41+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-phase-ii-trial-comparing-rituximabbendamustinerb-alter</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/iberoamerican-phase-iii-international-study-open-multicenter-random</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/role-of-senescent-cells-in-uterine-fibroid-pathogenesis</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-phase-ii-trial-of-combination-versus-single-agent-chemoth</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-phase-ib-open-label-clinical-trial-to-evaluate-the-safety-and-effica</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-blinded-placebo-controlled-phase-clinical-trial-of-re</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/phase-ii-study-of-bevacizumab-and-erlotinib-in-elderly-patients-with-a</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-pilot-study-to-assess-adherence-of-an-exercise-prescription-in-elder</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/double-blind-randomized-phase-iii-study-of-lenalidomide-maintenance-ve</loc><lastmod>2026-11-04T11:20:42+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/randomized-study-of-acvbp-plus-rituximab-versus-chop-plus-rituximab-in-2</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-phase-ii-study-of-elderly-and-frail-patients-with-newly-diagnosed-or</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/randomized-phase-iii-study-evaluating-the-non-inferiority-of-a-treatme</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-phase-ii-study-of-envafolimab-as-first-line-treatment-of-aged-patien</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/single-autologous-transplant-followed-by-consolidation-and-maintenance</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/semaforcranio-multicenter-double-blind-parallel-randomized-contro</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-phase-i-study-of-bendamustine-and-melphalan-conditioning-and-autolog</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/study-of-the-features-of-senescent-t-lymphocytes-induced-by-chemothera</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/radiotherapy-for-malignant-astrocytomas-in-the-elderly</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-open-label-phase-iii-study-comparing-pemetrexed-with-an</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/loc-r01-randomized-phase-ibii-study-of-escalating-doses-of-lenalidom</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-phase-iii-dose-escalation-study-of-a-vero-cell-derived-whole-virus</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-phase-iii-comparison-of-weekly-docetaxel-versus-weekly-do</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/what-are-reference-values-of-the-thickness-and-the-thickening-fraction</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-phase-iii-study-of-short-course-one-week-radiation-ther</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/reduced-intensity-allogeneic-hematopoietic-stem-cell-transplantation-i</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/evaluation-of-the-safety-and-immunogenicity-of-inactivated-sars-cov-2</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/radiotherapy-plus-durvalumab-in-elderly-esophageal-squamous-cell-carci</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-multi-center-randomized-double-blind-phase-iii-clinical-trial-to-a-4</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/immune-and-genetic-correlates-of-response-to-zoster-vaccine-in-the-fra</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/geriatric-g-assessment-guided-optimization-o-to-accelerate-functio</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/evaluation-of-bevacizumab-and-weekly-docetaxel-in-elderly-75-years</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/pilot-study-of-donor-lymphocyte-infusions-using-donor-t-cells-engineer</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/study-of-tg02-in-elderly-newly-diagnosed-or-adult-relapsed-patients-wi</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
  <url><loc>https://www.agingnexus.com/works/a-randomized-double-blinded-placebo-controlled-phase-clinical-t</loc><lastmod>2026-11-04T11:20:46+00:00</lastmod></url>
</urlset>